192 related articles for article (PubMed ID: 26132521)
1. Gold nanoparticles to improve HIV drug delivery.
Garrido C; Simpson CA; Dahl NP; Bresee J; Whitehead DC; Lindsey EA; Harris TL; Smith CA; Carter CJ; Feldheim DL; Melander C; Margolis DM
Future Med Chem; 2015; 7(9):1097-107. PubMed ID: 26132521
[TBL] [Abstract][Full Text] [Related]
2. Nevirapine Loaded Core Shell Gold Nanoparticles by Double Emulsion Solvent Evaporation: In vitro and In vivo Evaluation.
Dalvi BR; Siddiqui EA; Syed AS; Velhal SM; Ahmad A; Bandivdekar AB; Devarajan PV
Curr Drug Deliv; 2016; 13(7):1071-1083. PubMed ID: 26777885
[TBL] [Abstract][Full Text] [Related]
3. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain.
Asahchop EL; Meziane O; Mamik MK; Chan WF; Branton WG; Resch L; Gill MJ; Haddad E; Guimond JV; Wainberg MA; Baker GB; Cohen EA; Power C
Retrovirology; 2017 Oct; 14(1):47. PubMed ID: 29037245
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents.
Di Gianvincenzo P; Marradi M; Martínez-Avila OM; Bedoya LM; Alcamí J; Penadés S
Bioorg Med Chem Lett; 2010 May; 20(9):2718-21. PubMed ID: 20382017
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-mediated targeted delivery of antiretrovirals to the brain.
Mahajan SD; Law WC; Aalinkeel R; Reynolds J; Nair BB; Yong KT; Roy I; Prasad PN; Schwartz SA
Methods Enzymol; 2012; 509():41-60. PubMed ID: 22568900
[TBL] [Abstract][Full Text] [Related]
6. Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles.
Zhou T; Su H; Dash P; Lin Z; Dyavar Shetty BL; Kocher T; Szlachetka A; Lamberty B; Fox HS; Poluektova L; Gorantla S; McMillan J; Gautam N; Mosley RL; Alnouti Y; Edagwa B; Gendelman HE
Biomaterials; 2018 Jan; 151():53-65. PubMed ID: 29059541
[TBL] [Abstract][Full Text] [Related]
7. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.
Gong Y; Zhi K; Nagesh PKB; Sinha N; Chowdhury P; Chen H; Gorantla S; Yallapu MM; Kumar S
Viruses; 2020 May; 12(5):. PubMed ID: 32443728
[TBL] [Abstract][Full Text] [Related]
8. Stable HIV-1 integrase diversity during initial HIV-1 RNA decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy.
Noguera-Julian M; Casadellà M; Pou C; Rodríguez C; Pérez-Álvarez S; Puig J; Clotet B; Paredes R
Virol J; 2013 Dec; 10():350. PubMed ID: 24304606
[TBL] [Abstract][Full Text] [Related]
9. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
[TBL] [Abstract][Full Text] [Related]
10. Gold Nanocarriers for Macrophage-Targeted Therapy of Human Immunodeficiency Virus.
Zazo H; Colino CI; Warzecha KT; Hoss M; Gbureck U; Trautwein C; Tacke F; Lanao JM; Bartneck M
Macromol Biosci; 2017 Mar; 17(3):. PubMed ID: 27748547
[TBL] [Abstract][Full Text] [Related]
11. [Anti-HIV-1 activity and structure-activity relationship of pyranocoumarin analogs].
Dong B; Ma T; Zhang T; Zhou CM; Liu G; Wang L; Tao PZ; Zhang XQ
Yao Xue Xue Bao; 2011 Jan; 46(1):35-8. PubMed ID: 21465806
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV fusion with multivalent gold nanoparticles.
Bowman MC; Ballard TE; Ackerson CJ; Feldheim DL; Margolis DM; Melander C
J Am Chem Soc; 2008 Jun; 130(22):6896-7. PubMed ID: 18473457
[TBL] [Abstract][Full Text] [Related]
13. Small magnetite antiretroviral therapeutic nanoparticle probes for MRI of drug biodistribution.
Guo D; Li T; McMillan J; Sajja BR; Puligujja P; Boska MD; Gendelman HE; Liu XM
Nanomedicine (Lond); 2014 Jul; 9(9):1341-52. PubMed ID: 23905578
[TBL] [Abstract][Full Text] [Related]
14. Cell-free HIV-1 virucidal action by modified peptide triazole inhibitors of Env gp120.
Bastian AR; Kantharaju ; McFadden K; Duffy C; Rajagopal S; Contarino MR; Papazoglou E; Chaiken I
ChemMedChem; 2011 Aug; 6(8):1335-9, 1318. PubMed ID: 21714095
[No Abstract] [Full Text] [Related]
15. Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neurons.
Borgmann K; Rao KS; Labhasetwar V; Ghorpade A
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):853-62. PubMed ID: 21175357
[TBL] [Abstract][Full Text] [Related]
16. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.
Garg M; Asthana A; Agashe HB; Agrawal GP; Jain NK
J Pharm Pharmacol; 2006 May; 58(5):605-16. PubMed ID: 16640829
[TBL] [Abstract][Full Text] [Related]
17. Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.
Kanmogne GD; Singh S; Roy U; Liu X; McMillan J; Gorantla S; Balkundi S; Smith N; Alnouti Y; Gautam N; Zhou Y; Poluektova L; Kabanov A; Bronich T; Gendelman HE
Int J Nanomedicine; 2012; 7():2373-88. PubMed ID: 22661891
[TBL] [Abstract][Full Text] [Related]
18. Old plants newly discovered: Cassia sieberiana D.C. and Cassia abbreviata Oliv. Oliv. root extracts inhibit in vitro HIV-1c replication in peripheral blood mononuclear cells (PBMCs) by different modes of action.
Leteane MM; Ngwenya BN; Muzila M; Namushe A; Mwinga J; Musonda R; Moyo S; Mengestu YB; Abegaz BM; Andrae-Marobela K
J Ethnopharmacol; 2012 May; 141(1):48-56. PubMed ID: 22326358
[TBL] [Abstract][Full Text] [Related]
19. A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges.
Kovarova M; Swanson MD; Sanchez RI; Baker CE; Steve J; Spagnuolo RA; Howell BJ; Hazuda DJ; Garcia JV
J Antimicrob Chemother; 2016 Jun; 71(6):1586-96. PubMed ID: 27002074
[TBL] [Abstract][Full Text] [Related]
20. Efaverinz and nano-gold-loaded mannosylated niosomes: a host cell-targeted topical HIV-1 prophylaxis via thermogel system.
Malik T; Chauhan G; Rath G; Kesarkar RN; Chowdhary AS; Goyal AK
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):79-90. PubMed ID: 29231058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
